<DOC>
	<DOC>NCT01089855</DOC>
	<brief_summary>The trial is designed to evaluate the efficacy and tolerability of carbamazepine in neuropathic pain in diabetic patients</brief_summary>
	<brief_title>Efficacy and Tolerability of Carbamazepine CR in Diabetic Neuropathy Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>Diabetes patients with Diabetes neuropathy DN4 &gt; or equal to 4 Male or female aged from 21 to 65 years Informed consent HbA1C &lt; 11% Prior Hospitalization for Acido cetosis Prior hospitalization for severe hypoglycemia Pregnancy Hepatitis Diabetes foot AVB (auriculoventricular conduction disturbance) Patient treated by antidepressant drugs Patient treated with other antiepileptic drug Patients with blood ion disturbance Patient with neutropenia Glaucoma Bladder Adenoma Alcohol abuse Creatinin clearance &lt; 60 ml/ minute Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Neuropathic Pain</keyword>
	<keyword>Brief Pain Inventory</keyword>
	<keyword>DN4 questionnaire</keyword>
	<keyword>ElectroCardioGram</keyword>
</DOC>